197367-75-2 Usage
General Description
7-Oxo-4,7-dihydropyrazolo[1,5-a]pyrimidine-6-carboxylic acid is a heterocyclic compound with the chemical formula C6H4N4O3. It is a pyrazolopyrimidine derivative that is commonly used as an intermediate in the synthesis of pharmaceutical compounds. 7-Oxo-4,7-dihydropyrazolo[1,5-a]pyrimidine-6-carboxylic acid is known for its potential biological activities, including anti-inflammatory and anti-cancer properties. It is also used as a building block in the preparation of various pharmacologically active compounds. Overall, 7-Oxo-4,7-dihydropyrazolo[1,5-a]pyrimidine-6-carboxylic acid plays a crucial role in the development of new drugs and pharmaceutical agents.
Check Digit Verification of cas no
The CAS Registry Mumber 197367-75-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,7,3,6 and 7 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 197367-75:
(8*1)+(7*9)+(6*7)+(5*3)+(4*6)+(3*7)+(2*7)+(1*5)=192
192 % 10 = 2
So 197367-75-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H5N3O3/c11-6-4(7(12)13)3-8-5-1-2-9-10(5)6/h1-3,8H,(H,12,13)
197367-75-2Relevant articles and documents
Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors
Quattrini, Luca,Coviello, Vito,Sartini, Stefania,Da Settimo, Federico,La Motta, Concettina,Balestri, Francesco,Cappiello, Mario,Moschini, Roberta,Del Corso, Antonella,Mura, Umberto
, p. 1414 - 1418 (2018)
Aldose reductase (AKR1B1), the key enzyme of the polyol pathway, plays a crucial role in the development of long-term complications affecting diabetic patients. Nevertheless, the expedience of inhibiting this enzyme to treat diabetic complications has fai
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
-
, (2009/07/17)
The present invention relates to modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof of formula (I), including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention